Document is current
Any future updates will be listed below
-
Authors
Ogawa, Mariko https://orcid.org/0000-0002-4086-7130
Iioka, Yukiko https://orcid.org/0000-0003-0994-6751
Takamatsu, Kiyoshi https://orcid.org/0000-0001-6944-3342
- License Information
-
More Information
Article History
Received: 5 July 2024
Accepted: 31 October 2024
First Online: 7 December 2024
Declarations
:
: The ethics committee of Tokyo Dental College Ichikawa General Hospital approved this study (approval no. I 23-47, 2023).
: M. Ogawa received lecture fees from Otsuka Pharmaceutical, Bayer Yakuhin, Fuji Pharma, and ASKA Pharmaceutical; Y. Iioka has no conflicts of interest to disclose; K. Takamatsu received lecture fees from Otsuka Pharmaceutical, Bayer Yakuhin, Tsumura, Fuji Pharma, and Astellas Pharma.
